Seminars in Hematology
Volume 37, Issue 1 , Pages 91-101 , January 2000

Late clonal diseases of treated aplastic anemia

References 

  1. Appelbaum F, Barrall J, Storb R, et al.  Clonal cytogenetic abnormalities in patients with otherwise typical aplastic anemia. Exp Hematol. 1987;15:1134–1139
  2. Bacigalupo A, Broccia G, Corda G, et al.  Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): A pilot study of the EBMT SAA Working Party. Blood. 1995;85:1348–1353
  3. Ball SE, Gibson FM, Rizzo S, et al.  Progressive telomere shortening in aplastic anemia. Blood. 1998;91:3582–3592
  4. Browne PV, Lawler M, Humphries P, et al.  Donor-cell leukemia after bone marrow transplantation for severe aplastic anemia. N Engl J Med. 1991;325:710–713
  5. Cachia PG, Taylor C, Thompson PW, et al.  Non-dysplastic myelodysplasia. Leukemia. 1994;8:677–681
  6. Curtis RE, Rowlings PA, Deeg HJ, et al.  Solid cancers after bone marrow transplantation. N Engl J Med. 1997;336:897–904
  7. De Planque MM, Kluinnelemans HC, Van Krieken HJ, et al.  Evolution of acquired severe apastic anaemia to myelodysplastic and subsequent leukemia in adults. Br J Haematol. 1989;70:55–61
  8. De Planque MM, Bacigalupo A, Wursch A, et al.  Long-term follow-up of severe aplastic anaemia patients treated with antilymphocyte globulin. Br J Haematol. 1989;73:121–126
  9. Deeg HJ, Socie G, Schoch G, et al.  Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: A joint Seattle and Paris analysis of results in 700 patients. Blood. 1996;87:386–392
  10. Deeg HJ, Leisenring W, Storb R, et al.  Long-term outcome after marrow transplantation for severe aplastic anemia. Blood. 1998;91:3637–3645
  11. Delord C, Tooze JA, Saso R, et al.  Deficiency of glycosylphosphatidyl inositol-anchored proteins in patients with aplastic anaemia does not affect response to immunosuppressive therapy. Br J Haematol. 1998;101:90–93
  12. Doney K, Leisenring W, Storb R, et al.  Primary treatment of acquired aplastic anemia: Outcomes with bone marrow transplantation and immunosuppressive therapy. Ann Intern Med. 1997;126:107–107
  13. Frickhofen N, Schrezenmeier H, Bacigalupo A. Results of European trials of immunosuppression for treatment of aplastic anemia. In:  Gluckman E,  Coulombel L editor. Ontogeny of Hematopoiesis. Montrouge, France: Libbey; 1995;p. 335–344
  14. Gale RE, Fielding AK, Harrison CN, et al.  Acquired skewing of X-chromosome inactivation patterns in myeloid cells of the elderly suggests stochastic clonal loss with age. Br J Haematol. 1997;98:512–519
  15. Griscellibennaceur A, Gluckman E, Scrobohaci ML, et al.  Aplastic anemia and paroxysmal nocturnal hemoglobinuria: Search for a pathogenetic link. Blood. 1995;85:1354–1363
  16. Hillmen P, Lewis SM, Bessler M, et al.  Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med. 1995;333:1253–1258
  17. Josten KM, Tooze J, Borthwick-Clarke C, et al.  Acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria: Studies on clonality. Blood. 1991;78:3162–3167
  18. Kaito K, Kobayashi M, Katayama T, et al.  Long-term administration of G-CSF for aplastic anaemia is closely related to the early evolution of monosomy 7 MDS in adults. Br J Haematol. 1998;103:297–303
  19. Marsh JCW, Geary CG. Is aplastic anemia a pre-leukaemic disorder?. Br J Haematol. 1991;77:447–452
  20. Mikhailova N, Sessarego M, Fugazza G, et al.  Cytogenetic abnormalities in patients with severe aplastic anemia. Haematologica. 1996;81:418–422
  21. Najean Y, Haguenauer O. Evolution of non-grafted aplastic anemias. Blood. 1990;76:2222–2228
  22. Ohara A, Kojima S, Hamajima N, et al.  Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia. Blood. 1997;90:1009–1013
  23. Paquette RL, Tebyani N, Frane M, et al.  Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: Comparison with bone marrow transplantation. Blood. 1995;85:283–290
  24. Raghavachar A, Janssen JWG, Schrezenmeier H, et al.  Clonal hematopoiesis as defined by polymorphic X-linked loci occurs infrequently in aplastic anemia. Blood. 1995;86:2938–2947
  25. Rosenfeld SJ, Kimball J, Vining D, et al.  Intensive immuno-suppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood. 1995;85:3058–3065
  26. Rosse WF. Paroxysmal nocturnal hemoglobinuria as a molecular disease. Medicine (Baltimore). 1997;76:63–93
  27. Schrezenmeier H, Hertenstein B, Wagner B, et al.  A pathogenetic link between aplastic anemia and paroxysmal nocturnal hemoglobinuria is suggested by a high frequency of aplastic anemia patients with a deficiency of phosphatidylinositol glycan anchored proteins—Rapid Communication. Exp Hematol. 1995;23:81–87
  28. Schubert J, Vogt HG, Zielinskaskowronek M, et al.  Development of the glycosylphosphatitylinositol-anchoring defect characteristic for paroxysmal nocturnal hemoglobinuria in patients with aplastic anemia. Blood. 1994;83:2323–2328
  29. Socie G, Scieux C, Gluckman E, et al.  Squamous cell carcinomas after allogeneic bone marrow transplantation for aplastic anemia—Further evidence of a multistep process. Transplantation. 1998;66:667–670
  30. Socie G, Mary JY, Degramont A, et al.  Paroxysmal nocturnal haemoglobinuria: Long-term follow-up and prognostic factors. Lancet. 1996;348:573–577
  31. Socie G. Recent advances in paroxysmal nocturnal hemoglobinuria. From the biology to the clinic. Hematol Cell Ther. 1997;39:175–187
  32. Socie G, Henryamar M, Bacigalupo A, et al.  Malignant tumors occurring after treatment of aplastic anemia. N Engl J Med. 1993;329:1152–1157
  33. Socie G, Henryamar M, Cosset JM, et al.  Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia. Blood. 1991;78:277–279
  34. Tichelli A, Gratwohl A, Wursch A, et al.  Late haematological complications in severe aplastic anaemia. Br J Haematol. 1988;69:413–418
  35. Tichelli A, Gratwohl A, Nissen C, et al.  Late clonal complications in severe aplastic anemia. Leuk Lymphoma. 1994;12:167–175
  36. Tichelli A, Gratwohl A, Nissen C, et al.  Morphology in patients with severe aplastic anemia treated with antilymphocyte globulin. Blood. 1992;80:337–345
  37. Tooze J, Saso R, Marsh JCW, et al.  The novel monoclonal antibody By114 helps detect the early emergence of a paroxysmal nocturnal hemoglobinuria clone in aplastic anemia. Exp Hematol. 1995;23:1484–1491
  38. Vankamp H, Landegent JE, Jansen RPM, et al.  Clonal hematopoiesis in patients with acquired aplastic anemia. Blood. 1991;78:3209–3214
  39. Witherspoon RP, Storb R, Pepe M, et al.  Cumulative incidence of secondary solid malignant tumors in aplastic anemia given marrow grafts after conditioning with chemotherapy alone. Blood. 1991;79:289–291
  40. Yamaguchi M, Nakao S, Takamatsu H, et al.  Quality of hematologic recovery in patients with aplastic anemia following cyclosporine therapy. Exp Hematol. 1995;23:341–346
  41. Yamazaki E, Kanamori H, Taguchi J, et al.  The evidence of clonal evolution with monosomy 7 in aplastic anemia following granulocyte colony-stimulating factor using the polymerase chain reaction. Blood Cells Mol Dis. 1997;23:213–218
  42. Young NS. The problem of clonality in aplastic anemia: Dr Dameshek's riddle, restated. Blood. 1992;79:1385–1392

PII: S0037-1963(00)90033-7

Seminars in Hematology
Volume 37, Issue 1 , Pages 91-101 , January 2000

Article Tools